Skip to content
Home » HCV

HCV

Taking the Lead: Addressing the Critical Role of Communities in Research

  • Events

18 February, 2021 Much of the research which informs policy and decision making systemically excludes communities and key populations such as people who use drugs, people who live on the streets, transgender people, sex workers and men who have sex with men. Narratives which inform research projects too often come from academic backgrounds which are detached from real life issues.… Read More »Taking the Lead: Addressing the Critical Role of Communities in Research

Key Populations’ Values and Preferences for HIV, Hepatitis and STI services: A Qualitative Study

27 August, 2021 Pусский | Français | Español A summary report of our key findings from this study can be found here.Pусский | Français | Español  In 2021 INPUD collaborated with the World Health Organization (WHO) Department for Global HIV, Hepatitis and STI Programmes on a global qualitative study examining the values and preferences of key populations, including people who inject drugs, for HIV, Hepatitis and STIs services. The findings of this… Read More »Key Populations’ Values and Preferences for HIV, Hepatitis and STI services: A Qualitative Study

The IDUIT – Implementing Comprehensive HIV and HCV Programmes with People Who Inject Drugs

5 April, 2017 The IDUIT contains practical advice on implementing HIV and hepatitis C (HCV) programmes with people who inject drugs. It is based on recommendations in the WHO, UNODC, UNAIDS technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users – 2012 revision and the Consolidated guidelines on HIV prevention,… Read More »The IDUIT – Implementing Comprehensive HIV and HCV Programmes with People Who Inject Drugs